TABLE 2.
Univariate and multivariate Cox regression analyses of clinical characteristics associated with OS of LIHC.
| Characteristics | Total(N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p Value | Hazard ratio (95% CI) | p Value | ||
| T stage | 370 | ||||
| T1 | 183 | Reference | |||
| T2 | 94 | 1.428 (0.901−2.264) | 0.129 | 1.390 (0.755−2.561) | 0.291 |
| T3 and T4 | 93 | 2.949 (1.982−4.386) | <0.001 | 1.776 (0.238−13.258) | 0.575 |
| M stage | 272 | ||||
| M0 | 268 | Reference | |||
| M1 | 4 | 4.077 (1.281−12.973) | 0.017 | 1.110 (0.263−4.688) | 0.887 |
| Pathologic stage | 349 | ||||
| Stage I and Stage II | 259 | Reference | |||
| Stage III and Stage IV | 90 | 2.504 (1.727−3.631) | <0.001 | 1.483 (0.203−10.856) | 0.698 |
| Tumor status | 354 | ||||
| Tumor free | 202 | Reference | |||
| With tumor | 152 | 2.317 (1.590−3.376) | <0.001 | 1.915 (1.202−3.052) | 0.006 |
| PAFAH1B3 | 373 | 1.235 (1.095−1.392) | <0.001 | 1.198 (1.036−1.385) | 0.015 |